Immune injury in rat models of type 2 diabetes mellitus

被引:1
|
作者
Zou, Xiu-lan [1 ]
Yang, Jun [1 ]
Yang, Jian-ming [1 ]
Liu, Yan-qun [1 ]
Wang, Wen [1 ]
Zheng, Jun [1 ]
Ma, Bao-hua [1 ]
Chen, Fang-yuan [1 ]
机构
[1] Three Gorges Univ, Peoples Hosp, Peoples Hosp Yichang 1, Dept Endocrinol, Yichang 443000, Peoples R China
关键词
Diabetic cardiomyopathy; diet; high-sensitivity C-reactive protein; immunity; type 2 diabetes mellitus; COMPLEMENT;
D O I
10.5372/1905-7415.0605.137
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Diabetic cardiomyopathy is an important complication of type 2 diabetics. The role of immunoinflammation, immunity, and diet has not been adequately clarified. Objective: We investigated the relationships between diabetic cardiomyopathy and immuno-inflammation, as well as immunity and diets. Methods: Sixty Sprague-Dawley (SD) male rats were included in this study, from which 12 were randomly selected as the normal control group (group A) and of which the remaining 48 were considered as the type 2 diabetes mellitus (T2DM) model group. Group A was fed with common diets and the T2DM model group, with high-glucose diets (by adding 20% cane sugar, 10% lard, and 2.5% cholesterol into a 67.5% common diet). After 4-week feeding, the T2DM model group was randomly allocated into three groups according to the diet, high-fat diet group (group B), common diet group (group C), and low-fat diet group (group D). All the three groups were then fed for another 10 weeks. At the end of the experiment, body weight, random blood glucose levels, and cardiac weight were measured. Left ventricular tissue was obtained for light microscopy and electron microscopy. Deposits of immunoglobulin G (IgG) in myocardium were identified by immunohistochemistry. Serum levels of high-sensitivity C-reactive protein (hs-CRP) were determined using the enzyme-linked immunosorbent assay (ELISA). All data were statistically analyzed. Results: The serum level of hs-CRP was significantly higher in groups B, C, and D, than in the control group. Therefore, IgG deposits among cardiac muscle cells were observed in all the model groups, significant deviations were noted in group A (p < 0.01) and IgG deposits were less in group D than in groups B and C (p < 0.01). Conclusion: Immuno-inflammation participates in the development of T2DM and diabetic cardimyopathy. Immune injury can be alleviated following dietary interference.
引用
收藏
页码:903 / 908
页数:6
相关论文
共 50 条
  • [21] Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat
    Cummings, Bethany P.
    Digitale, Erin K.
    Stanhope, Kimber L.
    Graham, James L.
    Baskin, Denis G.
    Reed, Benjamin J.
    Sweet, Ian R.
    Griffen, Steven C.
    Havel, Peter J.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2008, 295 (06) : R1782 - R1793
  • [22] Immune therapy in type 1 diabetes mellitus
    Åke Lernmark
    Helena Elding Larsson
    Nature Reviews Endocrinology, 2013, 9 : 92 - 103
  • [23] Type 2 diabetes mellitus: a disease of the innate immune system? An update
    Crook, M
    DIABETIC MEDICINE, 2004, 21 (03) : 203 - 207
  • [24] The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
    Daryabor, Gholamreza
    Atashzar, Mohamad Reza
    Kabelitz, Dieter
    Meri, Seppo
    Kalantar, Kurosh
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [25] Immune intervention for type 1 diabetes mellitus
    Skyler, J. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 : 61 - 70
  • [26] Immune Interventions for Type 1 Diabetes Mellitus
    Nambam, Bimota
    Bratina, Natasa
    Schatz, Desmond
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 : S74 - S81
  • [27] Exosomes as Emerging Regulators of Immune Responses in Type 2 Diabetes Mellitus
    Zheng, Wei
    Ji, Xin
    Yin, Qiao qiao
    Wu, Chensi
    Xu, Chengan
    Pan, Hongying
    Wu, Chun
    JOURNAL OF DIABETES RESEARCH, 2024, 2024
  • [28] Correlations of sleep disturbance with the immune system in type 2 diabetes mellitus
    Tsujimura, Takahiro
    Matsuo, Yoshinobu
    Keyaki, Takahiro
    Sakurada, Kumi
    Imanishi, Jiro
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 85 (03) : 286 - 292
  • [29] Immune therapy in type 1 diabetes mellitus
    Lernmark, Ake
    Larsson, Helena Elding
    NATURE REVIEWS ENDOCRINOLOGY, 2013, 9 (02) : 92 - 103
  • [30] Overtreatment in type 2 diabetes mellitus; [Overbehandeling bij diabetes mellitus type 2]
    Khachadurian S.
    van Beek C.
    Rutten G.
    Huisarts en wetenschap, 2018, 61 (5) : 44 - 47